Biorelate offers free access to AI drug discovery tool
The company is granting researchers free use of cloud-based Galactic AI technology while the COVID-19 pandemic continues to impact labs worldwide.
The company is granting researchers free use of cloud-based Galactic AI technology while the COVID-19 pandemic continues to impact labs worldwide.
SubjectWell has launched a registry giving researchers access to tens of thousands expressing interest in contributing to COVID-19 clinical trials.